Tecentriq misses mark in ovarian cancer trial
The drug did not extend progression-free survival in patients with newly diagnosed advanced stage ovarian cancer
14th July 2020
Latest news
US fast tracks Pfizer/BioNTech coronavirus vaccines
The mRNA-based vaccines are currently being evaluated in Phase I/II clinical trials in Germany and the US
14th July 2020
ICR/Cyclacel scientists discover new cancer drug
Fadraciclib is a dual inhibitor of CDK2 and CDK9
14th July 2020
'Prepare now for winter COVID-19 peak', says Academy of Medical Sciences
COVID-19 deaths could reach 119,000 between September 2020 and June 2021 if no action is taken
14th July 2020
Clinigen's ALS therapy bags US orphan status
Clinigen has bagged a US orphan drug designation (ODD) for its investigational Amyotrophic Lateral Sclerosis (ALS) treatment aldesleukin.
13th July 2020
NICE links with Colombia’s Institute of Health Technology Assessment
The two agencies have agreed to share research and knowledge
13th July 2020
Experimental motor neurone disease therapy shows early promise
Phase I/II study results demonstrate proof-of-concept and proof-of-biology of tofersen
13th July 2020
UK report finds low awareness of non-melanoma skin cancer
More than 152,000 new cases of NMSC are diagnosed every year - more than breast, prostate and lung cancers combined
13th July 2020
Bayer's finerenone hits targets in diabetes/kidney disease trial
The drug hit primary and secondary goals of the Phase III FIDELIO-DKD renal outcomes study
10th July 2020
Research journals commit to action on equality
Joint commitment led by the Royal Society of Chemistry, which has created a framework to reduce bias and discrimination that it is hoped 'will help reshape journals all over the world'
10th July 2020
US priority review for AZ' Brilinta/aspirin combination
Brilinta/aspirin combo could be the first US-approved dual antiplatelet therapy to cut risk of second stroke
10th July 2020
Charity warns of 'catastrophic' effect of COVID-19 on stroke research
UK’s leading stroke charity warns research faces long-term threat due to coronavirus pandemic
10th July 2020
NICE backing for Takeda's Adcetris for rare lymphoma
Standard of care in untreated systemic anaplastic large cell lymphoma (sALCL) has not changed in several decades
10th July 2020
CMA levies fines of £2.3m in pharma probe
The fines are in addition to £8 million secured for the NHS last year as part of the case
9th July 2020
US rejects MSD/Eisai's Keytruda Lenvima combo
Regulators rejected accelerated approval as Roche's combination for the same patient population made it over the line first
9th July 2020
